0      0


Exhibit Hall Presentation: An Overview of Clinical Data for ENHERTU® (fam-trastuzumab deruxtecan-nxki) in 2L HER2+ Metastatic Breast Cancer <br> Daiichi-Sankyo</br>


‐ Nov 11, 2023 11:00am

Nikita C. Shah, MD